Amgen Inc. buy Piper Jaffray Companies
Start price
02.01.25
/
50%
€254.50
Target price
02.01.26
€300.51
Performance (%)
8.92%
End price
03.01.26
€277.20
Summary
This prediction ended on 03.01.26 with a price of €277.20. The BUY prediction by Piper_Jaffray_Compan finished with a performance of 8.92%. Dividends of €9.41 are taken into consideration when calculating the performance. Piper_Jaffray_Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amgen Inc. | 8.288% | 8.288% | 11.498% |
| iShares Core DAX® | -1.020% | 0.271% | 13.941% |
| iShares Nasdaq 100 | -3.122% | -1.929% | 1.920% |
| iShares Nikkei 225® | 0.649% | 6.582% | 21.176% |
| iShares S&P 500 | -0.142% | -0.295% | 1.363% |
Comments by Piper_Jaffray_Compan for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its "overweight" rating re-affirmed by analysts at Piper Sandler Companies. They now have a $310.00 price target on the stock.
Ratings data for AMGN provided by MarketBeat
In the thread Trading Amgen Inc.
Die von Piper_Jaffray_Compan gewählte maximale Laufzeit wurde überschritten